Results 191 to 200 of about 177,182 (340)

Proposing the ValvUS approach: integrating bedside tests and ultrasonography for severe valvular heart disease diagnosis. [PDF]

Einstein (Sao Paulo)
Accorsi TAD, Ribeiro HB, Pessoa RS, Nemoto RP, Mathias Junior W, Pibarot P, Tarasoutchi F.   +6 more
europepmc   +1 more source

Same evidence different recommendations: a methodological assessment of transatlantic guidelines for the management of valvular heart disease [PDF]

Milan Milojevic, Miguel Sousa‐Uva, Mateo Marín-Cuartas, Sanjay Kaul, Aleksandar Nikolić, John Mandrola, Rafael Sádaba, Patrick O. Myers   +7 more
openalex   +1 more source

Progress in Valvular Heart Disease and Arrhythmias in 2022

, 2023
Wataru Tatsuishi
openalex   +2 more sources

Left Ventricular Outflow Tract Geometry as a Predictor of Permanent Pacemaker Implantation After Transcatheter Aortic Valve Implantation Using the Evolut Series

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Predicting the need for permanent pacemaker implantation (PPM) after transcatheter aortic valve implantation (TAVI) is crucial for procedural planning and patient counseling. Aims To evaluate whether left ventricular outflow tract (LVOT) morphology, specifically a tapered configuration, predicts conduction disturbances requiring PPM
Mahmoud Abdelshafy, Angela McInerney, Ahmed Elmeanawy, Paolo Alberto Del Sole, Max Wagener, Hatem Helal, Mahmoud Abozaid, Ashraf Alamir, Tamer Fouad, Alsayed Almarghany, Briain MacNeill, Osama Soliman, Darren Mylotte, Mohammad Abdelghani   +13 more
wiley   +1 more source

Mitral Annulus Dynamics: Another Unmet Need in Valvular Heart Disease. [PDF]

Echocardiography
Morariu PC, Floria M, Floria DE, Tanase DM.   +3 more
europepmc   +1 more source

The burden of nonrheumatic valvular heart diseases in Iran between 1990 and 2017: Results from the global burden of disease study 2017

, 2022
Jalal Arabloo, Negar Omidi, Aziz Rezapour, Ali Sarabi Asiabar, Seyyed Mojtaba Ghorashi, Samad Azari   +5 more
openalex   +1 more source

Real‐World Edoxaban Concentrations in Older Patients Receiving Reduced‐Dose Regimens

Clinical Pharmacology &Therapeutics, EarlyView.
Real‐world edoxaban concentrations in older patients receiving reduced‐dose regimens. Low trough concentrations (< 12 ng/mL) were associated with an increased risk of thromboembolism. Among patients meeting the ELDERCARE‐AF criteria, low drug levels were more frequent with the 15 mg regimen than with the 30 mg regimen.
Sung‐Chun Tang, Shin‐Yi Lin, Chih‐Hao Chen, Yen‐Bin Liu, Li‐Ting Ho, Ching‐Hua Kuo, Yu‐Fong Peng, Chih‐Fen Huang, Jiann‐Shing Jeng   +8 more
wiley   +1 more source

Valvular Heart Disease and Its Association With Death in Advanced Heart Failure. [PDF]

J Am Heart Assoc
Steiger KG, Harmon DM, Killian JM, Nkomo VT, Redfield M, Dunlay SM.   +5 more
europepmc   +1 more source

Hybrid surgery of valvular heart disease and atrial fibrillation [PDF]

, 2017
A.S. Zhigalkovich, Yu. P. Ostrovsky
openalex   +1 more source

Pediatric Developmental Safety Assessment: Are We Ready for the Next Thalidomide?

Clinical Pharmacology &Therapeutics, EarlyView.
Pediatric drug development has achieved remarkable success in the last 20 years with over 1,000 products studied in pediatric patients. This success has been driven in part by an increased understanding of pediatric disease processes. The aspect that has been largely overlooked is the potential adverse effect of new drugs on pediatric developmental ...
Gilbert J. Burckart, Susan M. Abdel‐Rahman, Gelareh Abulwerdi, Sherbet Samuels, Rebecca Racz, Mohamed A. Mohamoud, Nicholas P. Tatonetti   +6 more
wiley   +1 more source